| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 604586 | 2-Butenamide, N-(4-chlorophenyl)-4,4,4-trichloro- | 0.0430505868034764 | 0.33395821 |
| NSC 628591 | Null | 0.0430505868034764 | 0.27967509 |
| NSC 641319 | 5,12-Naphthacenedione, 10-[[3-[[5,5-di(acetyloxy)pentyl]amino]- 2,3,6-trideoxy-.alpha.-L-lyxohexopyranosyl]oxy]- 7,8,9,10-tetrahydro-6,8,11-trihydroxy- 8-(hydroxyacetyl)-1-methoxy-, hydrochloride | 0.0430505868034764 | 0.47662765 |
| NSC 644945 | Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6-one, 5,5a,6,8,8a,9-hexahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)- 9-[2-(dimethylamino)ethoxy]-, stereoisomer, hydrochloride | 0.0430505868034764 | 0.28835144 |
| NSC 645210 | 1,4-Naphthalenedione, 2-chloro-3-[[2-(2-fluorophenyl)- 1-oxoethyl]amino]- | 0.0430505868034764 | 0.28568475 |
| NSC 654509 | Pirarubicin HCl | 0.0430505868034764 | 0.3782688 |
| NSC 65628 | Null | 0.0430505868034764 | 0.44575184 |
| NSC 658828 | Null | 0.0430505868034764 | 0.27520665 |
| NSC 666112 | Null | 0.0430505868034764 | 0.29497151 |
| NSC 668332 | Null | 0.0430505868034764 | 0.3539604 |